Intervention

ketamine hydrochloride

ClinicalTrials.gov intervention label

Clinical trials4

Recruiting2

Common conditions6

Lead sponsors shown4

Clinical trials

4 shown

Understanding and Treating Suicidal Ideation With KetamineNCT06891300 · 2025-04-08

Imaging Depression in Parkinson's DiseaseNCT06402955 · 2024-09-01

Chart Review of Patients Undergoing Ketamine Treatments for DepressionNCT07099235 · 2022-04-01

Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic PainNCT01316744 · 2009-04-01

Common conditions

Cancer1 Depression - Major Depressive Disorder1 Major Depressive Disorder1 Major Depressive Disorder (MDD)1 Parkinson's Disease1 Suicidal Ideation1

Leading sponsors

Sunnybrook Health Sciences Centre1 The Royal's Institute of Mental Health Research1 University of Glasgow1 Yale University1

Trial status mix

RECRUITING2

COMPLETED1

UNKNOWN1

Phase mix

PHASE22

PHASE32

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.